Work

Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy

Year: 2001

Type: article

Source: European Journal of Immunology

DOI: 10.1002/1521-4141(200105)31:5<1351::aid-immu1351>3.0.co;2-9

Authors: Joseph A. Kovacs, Susan Vogel, Julia A. Metcalf, Michael Baseler, Randy Stevens, Joseph Adelsberger, Richard Lempicki, Richard L. Hengel, Irini Sereti, Laurie Lambert, Robin L. Dewar, Richard T. Davey, Robert E. Walker, Judith Falloon, Michael A. Polis, Henry Masur, H. Clifford Lane

Institutions: National Institutes of Health, National Institutes of Health Clinical Center, National Institute of Allergy and Infectious Diseases, Science Applications International Corporation (United States), Georgetown University

Language: English

Topic: HIV Research and Treatment

Subfield: Virology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G3029148, OPERATIONS &TECHNICAL SUPPORT

OpenAlex ID: W2067601243

FWCI: 3.014

Cites: 21

Cited by: 55

Related to: 10